List of Tables
Table 1. Noninvasive Vaccination Market Trends
Table 2. Noninvasive Vaccination Market Drivers & Opportunity
Table 3. Noninvasive Vaccination Market Challenges
Table 4. Noninvasive Vaccination Market Restraints
Table 5. Global Noninvasive Vaccination Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Noninvasive Vaccination Revenue Market Share by Company (2019-2024)
Table 7. Global Noninvasive Vaccination Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Noninvasive Vaccination Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Noninvasive Vaccination Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Noninvasive Vaccination Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Noninvasive Vaccination Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Noninvasive Vaccination
Table 13. Global Noninvasive Vaccination Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Noninvasive Vaccination as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Noninvasive Vaccination Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Noninvasive Vaccination Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Noninvasive Vaccination Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Noninvasive Vaccination Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Noninvasive Vaccination Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Noninvasive Vaccination Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Noninvasive Vaccination Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Noninvasive Vaccination Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Noninvasive Vaccination Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Noninvasive Vaccination Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Noninvasive Vaccination Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Noninvasive Vaccination Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Noninvasive Vaccination Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Noninvasive Vaccination Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Noninvasive Vaccination Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Noninvasive Vaccination Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Noninvasive Vaccination Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Noninvasive Vaccination Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Noninvasive Vaccination Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Noninvasive Vaccination Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Noninvasive Vaccination Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Noninvasive Vaccination Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Noninvasive Vaccination Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Noninvasive Vaccination Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Noninvasive Vaccination Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Noninvasive Vaccination Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Noninvasive Vaccination Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Noninvasive Vaccination Sales Value by Region (2019-2024) & (%)
Table 44. Global Noninvasive Vaccination Sales Value by Region (2025-2030) & (%)
Table 45. Global Noninvasive Vaccination Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Noninvasive Vaccination Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Noninvasive Vaccination Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Noninvasive Vaccination Sales Volume by Region (2019-2024) & (%)
Table 49. Global Noninvasive Vaccination Sales Volume by Region (2025-2030) & (%)
Table 50. Global Noninvasive Vaccination Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Noninvasive Vaccination Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Noninvasive Vaccination Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Noninvasive Vaccination Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Noninvasive Vaccination Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Noninvasive Vaccination Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Noninvasive Vaccination Sales Volume, (2025-2030) & (K Units)
Table 57. Merck Company Information
Table 58. Merck Introduction and Business Overview
Table 59. Merck Noninvasive Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Merck Noninvasive Vaccination Product Offerings
Table 61. Merck Recent Development
Table 62. GSK Company Information
Table 63. GSK Introduction and Business Overview
Table 64. GSK Noninvasive Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. GSK Noninvasive Vaccination Product Offerings
Table 66. GSK Recent Development
Table 67. Sanofi Company Information
Table 68. Sanofi Introduction and Business Overview
Table 69. Sanofi Noninvasive Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Sanofi Noninvasive Vaccination Product Offerings
Table 71. Sanofi Recent Development
Table 72. Lanzhou Institute Company Information
Table 73. Lanzhou Institute Introduction and Business Overview
Table 74. Lanzhou Institute Noninvasive Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Lanzhou Institute Noninvasive Vaccination Product Offerings
Table 76. Lanzhou Institute Recent Development
Table 77. Serum Institute Company Information
Table 78. Serum Institute Introduction and Business Overview
Table 79. Serum Institute Noninvasive Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Serum Institute Noninvasive Vaccination Product Offerings
Table 81. Serum Institute Recent Development
Table 82. Valneva Company Information
Table 83. Valneva Introduction and Business Overview
Table 84. Valneva Noninvasive Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Valneva Noninvasive Vaccination Product Offerings
Table 86. Valneva Recent Development
Table 87. Shanghai United Cell Company Information
Table 88. Shanghai United Cell Introduction and Business Overview
Table 89. Shanghai United Cell Noninvasive Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Shanghai United Cell Noninvasive Vaccination Product Offerings
Table 91. Shanghai United Cell Recent Development
Table 92. Bibcol Company Information
Table 93. Bibcol Introduction and Business Overview
Table 94. Bibcol Noninvasive Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Bibcol Noninvasive Vaccination Product Offerings
Table 96. Bibcol Recent Development
Table 97. PaxVax Company Information
Table 98. PaxVax Introduction and Business Overview
Table 99. PaxVax Noninvasive Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. PaxVax Noninvasive Vaccination Product Offerings
Table 101. PaxVax Recent Development
Table 102. Vabiotech Company Information
Table 103. Vabiotech Introduction and Business Overview
Table 104. Vabiotech Noninvasive Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Vabiotech Noninvasive Vaccination Product Offerings
Table 106. Vabiotech Recent Development
Table 107. Tiantan Biological Company Information
Table 108. Tiantan Biological Introduction and Business Overview
Table 109. Tiantan Biological Noninvasive Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Tiantan Biological Noninvasive Vaccination Product Offerings
Table 111. Tiantan Biological Recent Development
Table 112. EuBiologics Company Information
Table 113. EuBiologics Introduction and Business Overview
Table 114. EuBiologics Noninvasive Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. EuBiologics Noninvasive Vaccination Product Offerings
Table 116. EuBiologics Recent Development
Table 117. Panacea Biotec Ltd Company Information
Table 118. Panacea Biotec Ltd Introduction and Business Overview
Table 119. Panacea Biotec Ltd Noninvasive Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Panacea Biotec Ltd Noninvasive Vaccination Product Offerings
Table 121. Panacea Biotec Ltd Recent Development
Table 122. Bio-Med Company Information
Table 123. Bio-Med Introduction and Business Overview
Table 124. Bio-Med Noninvasive Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Bio-Med Noninvasive Vaccination Product Offerings
Table 126. Bio-Med Recent Development
Table 127. Halfkin Bio-Pharmaceuticals Company Information
Table 128. Halfkin Bio-Pharmaceuticals Introduction and Business Overview
Table 129. Halfkin Bio-Pharmaceuticals Noninvasive Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Halfkin Bio-Pharmaceuticals Noninvasive Vaccination Product Offerings
Table 131. Halfkin Bio-Pharmaceuticals Recent Development
Table 132. AstraZeneca Company Information
Table 133. AstraZeneca Introduction and Business Overview
Table 134. AstraZeneca Noninvasive Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 135. AstraZeneca Noninvasive Vaccination Product Offerings
Table 136. AstraZeneca Recent Development
Table 137. Cipla Company Information
Table 138. Cipla Introduction and Business Overview
Table 139. Cipla Noninvasive Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 140. Cipla Noninvasive Vaccination Product Offerings
Table 141. Cipla Recent Development
Table 142. BCHT Company Information
Table 143. BCHT Introduction and Business Overview
Table 144. BCHT Noninvasive Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 145. BCHT Noninvasive Vaccination Product Offerings
Table 146. BCHT Recent Development
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Noninvasive Vaccination Downstream Customers
Table 150. Noninvasive Vaccination Distributors List
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Noninvasive Vaccination Product Picture
Figure 2. Global Noninvasive Vaccination Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Noninvasive Vaccination Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Noninvasive Vaccination Sales Volume (2019-2030) & (K Units)
Figure 5. Global Noninvasive Vaccination Sales Price (2019-2030) & (US$/Unit)
Figure 6. Noninvasive Vaccination Report Years Considered
Figure 7. Global Noninvasive Vaccination Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Noninvasive Vaccination Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Noninvasive Vaccination Revenue in 2023
Figure 10. Noninvasive Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Oral Vaccine Picture
Figure 12. Nasal Spray Vaccine Picture
Figure 13. Global Noninvasive Vaccination Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Noninvasive Vaccination Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Noninvasive Vaccination Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Noninvasive Vaccination Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Noninvasive Vaccination Price by Type (2019-2030) & (US$/Unit)
Figure 18. Product Picture of Public
Figure 19. Product Picture of Private
Figure 20. Global Noninvasive Vaccination Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Noninvasive Vaccination Sales Value Market Share by Application, 2023 & 2030
Figure 22. Global Noninvasive Vaccination Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 23. Global Noninvasive Vaccination Sales Volume Market Share by Application, 2023 & 2030
Figure 24. Global Noninvasive Vaccination Price by Application (2019-2030) & (US$/Unit)
Figure 25. North America Noninvasive Vaccination Sales Value (2019-2030) & (US$ Million)
Figure 26. North America Noninvasive Vaccination Sales Value by Country (%), 2023 VS 2030
Figure 27. Europe Noninvasive Vaccination Sales Value (2019-2030) & (US$ Million)
Figure 28. Europe Noninvasive Vaccination Sales Value by Country (%), 2023 VS 2030
Figure 29. Asia Pacific Noninvasive Vaccination Sales Value (2019-2030) & (US$ Million)
Figure 30. Asia Pacific Noninvasive Vaccination Sales Value by Country (%), 2023 VS 2030
Figure 31. South America Noninvasive Vaccination Sales Value (2019-2030) & (US$ Million)
Figure 32. South America Noninvasive Vaccination Sales Value by Country (%), 2023 VS 2030
Figure 33. Middle East & Africa Noninvasive Vaccination Sales Value (2019-2030) & (US$ Million)
Figure 34. Middle East & Africa Noninvasive Vaccination Sales Value by Country (%), 2023 VS 2030
Figure 35. Key Countries/Regions Noninvasive Vaccination Sales Value (%), (2019-2030)
Figure 36. Key Countries/Regions Noninvasive Vaccination Sales Volume (%), (2019-2030)
Figure 37. United States Noninvasive Vaccination Sales Value, (2019-2030) & (US$ Million)
Figure 38. United States Noninvasive Vaccination Sales Value by Type (%), 2023 VS 2030
Figure 39. United States Noninvasive Vaccination Sales Value by Application (%), 2023 VS 2030
Figure 40. Europe Noninvasive Vaccination Sales Value, (2019-2030) & (US$ Million)
Figure 41. Europe Noninvasive Vaccination Sales Value by Type (%), 2023 VS 2030
Figure 42. Europe Noninvasive Vaccination Sales Value by Application (%), 2023 VS 2030
Figure 43. China Noninvasive Vaccination Sales Value, (2019-2030) & (US$ Million)
Figure 44. China Noninvasive Vaccination Sales Value by Type (%), 2023 VS 2030
Figure 45. China Noninvasive Vaccination Sales Value by Application (%), 2023 VS 2030
Figure 46. Japan Noninvasive Vaccination Sales Value, (2019-2030) & (US$ Million)
Figure 47. Japan Noninvasive Vaccination Sales Value by Type (%), 2023 VS 2030
Figure 48. Japan Noninvasive Vaccination Sales Value by Application (%), 2023 VS 2030
Figure 49. South Korea Noninvasive Vaccination Sales Value, (2019-2030) & (US$ Million)
Figure 50. South Korea Noninvasive Vaccination Sales Value by Type (%), 2023 VS 2030
Figure 51. South Korea Noninvasive Vaccination Sales Value by Application (%), 2023 VS 2030
Figure 52. Southeast Asia Noninvasive Vaccination Sales Value, (2019-2030) & (US$ Million)
Figure 53. Southeast Asia Noninvasive Vaccination Sales Value by Type (%), 2023 VS 2030
Figure 54. Southeast Asia Noninvasive Vaccination Sales Value by Application (%), 2023 VS 2030
Figure 55. India Noninvasive Vaccination Sales Value, (2019-2030) & (US$ Million)
Figure 56. India Noninvasive Vaccination Sales Value by Type (%), 2023 VS 2030
Figure 57. India Noninvasive Vaccination Sales Value by Application (%), 2023 VS 2030
Figure 58. Noninvasive Vaccination Industrial Chain
Figure 59. Noninvasive Vaccination Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
